[Nephrocalcinosis following administration of dihydrotachysterol].
D004097:Dihydrotachysterol / Q000009:adverse effects*; D006042:Goiter / Q000601:surgery; D006801:Humans; D007011:Hypoparathyroidism / Q000188:drug therapy; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D009397:Nephrocalcinosis / Q000188:drug therapy*; D013963:Thyroid Hormones / Q000627:therapeutic use; D013965:Thyroidectomy
D013963:Thyroid Hormones; D004097:Dihydrotachysterol
Nephrokalzinose nach Dihydrotachysterin-Medikation.